 Elan Eisenmesser
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclophilin A | 13 | 2017 | 24 | 2.640 |
Why?
| | Streptococcus pneumoniae | 3 | 2020 | 133 | 1.780 |
Why?
| | Basigin | 5 | 2017 | 25 | 1.780 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 22 | 2020 | 238 | 1.690 |
Why?
| | Cyclophilins | 7 | 2023 | 29 | 1.690 |
Why?
| | Virulence Factors | 3 | 2022 | 139 | 1.430 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 2 | 2020 | 20 | 1.330 |
Why?
| | Models, Molecular | 25 | 2021 | 1369 | 1.300 |
Why?
| | Interleukin-1 | 8 | 2021 | 966 | 1.250 |
Why?
| | Serine Endopeptidases | 2 | 2020 | 102 | 1.240 |
Why?
| | Bacterial Proteins | 5 | 2023 | 736 | 1.060 |
Why?
| | Thermodynamics | 3 | 2020 | 382 | 1.010 |
Why?
| | Protein Conformation | 16 | 2021 | 805 | 0.960 |
Why?
| | Molecular Dynamics Simulation | 5 | 2017 | 201 | 0.850 |
Why?
| | Metalloproteases | 1 | 2022 | 37 | 0.820 |
Why?
| | Immunoglobulin A | 1 | 2022 | 166 | 0.760 |
Why?
| | Protein Binding | 17 | 2020 | 1889 | 0.760 |
Why?
| | Catalytic Domain | 8 | 2020 | 196 | 0.740 |
Why?
| | Mutation | 4 | 2021 | 3344 | 0.720 |
Why?
| | Bacteria | 4 | 2023 | 725 | 0.710 |
Why?
| | Crystallography, X-Ray | 11 | 2020 | 402 | 0.710 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.700 |
Why?
| | Protease Inhibitors | 1 | 2020 | 97 | 0.690 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2019 | 473 | 0.630 |
Why?
| | Erythrocytes | 5 | 2021 | 591 | 0.630 |
Why?
| | Coenzymes | 1 | 2018 | 16 | 0.620 |
Why?
| | Binding Sites | 10 | 2021 | 1168 | 0.570 |
Why?
| | RNA | 1 | 2023 | 809 | 0.560 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 796 | 0.560 |
Why?
| | Immune Tolerance | 1 | 2019 | 323 | 0.550 |
Why?
| | Energy Metabolism | 3 | 2021 | 731 | 0.550 |
Why?
| | Geobacillus | 2 | 2015 | 2 | 0.550 |
Why?
| | Valine | 1 | 2017 | 72 | 0.540 |
Why?
| | Protein Structure, Secondary | 8 | 2017 | 325 | 0.530 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 84 | 0.530 |
Why?
| | Protein Folding | 5 | 2017 | 239 | 0.520 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 138 | 0.510 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2015 | 1 | 0.490 |
Why?
| | Receptors, Interleukin-8A | 1 | 2014 | 5 | 0.460 |
Why?
| | Interleukin-8 | 2 | 2020 | 237 | 0.460 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 104 | 0.460 |
Why?
| | Peptides | 4 | 2014 | 848 | 0.460 |
Why?
| | Immunity, Innate | 2 | 2019 | 720 | 0.450 |
Why?
| | Catalysis | 11 | 2017 | 289 | 0.440 |
Why?
| | Extracellular Space | 1 | 2013 | 116 | 0.420 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 119 | 0.420 |
Why?
| | Recombinant Proteins | 7 | 2020 | 1230 | 0.410 |
Why?
| | Temperature | 2 | 2012 | 565 | 0.410 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 153 | 0.410 |
Why?
| | Interleukin-6 | 3 | 2021 | 676 | 0.400 |
Why?
| | Blood Preservation | 3 | 2021 | 263 | 0.400 |
Why?
| | Peptidylprolyl Isomerase | 4 | 2017 | 10 | 0.380 |
Why?
| | Humans | 48 | 2023 | 114623 | 0.380 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 502 | 0.360 |
Why?
| | Interleukin-13 | 2 | 2001 | 122 | 0.360 |
Why?
| | Protein Domains | 3 | 2023 | 207 | 0.350 |
Why?
| | Interleukins | 3 | 2023 | 236 | 0.350 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 731 | 0.340 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 22 | 0.340 |
Why?
| | Biocatalysis | 2 | 2020 | 58 | 0.320 |
Why?
| | Nucleocapsid Proteins | 2 | 2023 | 24 | 0.300 |
Why?
| | Amino Acid Sequence | 9 | 2020 | 1982 | 0.300 |
Why?
| | Immunologic Factors | 2 | 2021 | 220 | 0.300 |
Why?
| | DNA Viruses | 1 | 2007 | 9 | 0.290 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 162 | 0.290 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 399 | 0.280 |
Why?
| | Exercise Tolerance | 2 | 2019 | 213 | 0.280 |
Why?
| | Amino Acid Motifs | 2 | 2017 | 197 | 0.270 |
Why?
| | Substrate Specificity | 3 | 2017 | 352 | 0.270 |
Why?
| | Viral Proteins | 1 | 2007 | 281 | 0.250 |
Why?
| | Anti-Inflammatory Agents | 3 | 2021 | 447 | 0.250 |
Why?
| | Cell Line | 5 | 2021 | 2635 | 0.250 |
Why?
| | Peptide Fragments | 2 | 2000 | 665 | 0.240 |
Why?
| | Ligands | 4 | 2019 | 561 | 0.240 |
Why?
| | Animals | 18 | 2023 | 31694 | 0.240 |
Why?
| | Oxidative Stress | 3 | 2021 | 1076 | 0.240 |
Why?
| | Receptors, Interleukin-1 | 3 | 2021 | 228 | 0.240 |
Why?
| | Molecular Sequence Data | 7 | 2014 | 2785 | 0.240 |
Why?
| | Protein Multimerization | 2 | 2019 | 157 | 0.240 |
Why?
| | Antibodies, Monoclonal | 2 | 2021 | 1262 | 0.230 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 2 | 2023 | 19 | 0.230 |
Why?
| | Inflammation | 6 | 2021 | 2477 | 0.230 |
Why?
| | Enzyme Stability | 2 | 2015 | 62 | 0.230 |
Why?
| | Mammals | 2 | 2023 | 244 | 0.230 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 15 | 0.220 |
Why?
| | NAD | 1 | 2023 | 63 | 0.220 |
Why?
| | Nucleocapsid | 1 | 2023 | 17 | 0.220 |
Why?
| | Amino Acids | 2 | 2017 | 448 | 0.210 |
Why?
| | Blood Donors | 2 | 2021 | 89 | 0.210 |
Why?
| | Streptococcus | 1 | 2022 | 22 | 0.210 |
Why?
| | Serine | 1 | 2023 | 126 | 0.200 |
Why?
| | Blood Banks | 2 | 2021 | 40 | 0.200 |
Why?
| | NADP | 2 | 2021 | 43 | 0.200 |
Why?
| | HEK293 Cells | 2 | 2021 | 591 | 0.200 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 146 | 0.200 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 66 | 0.200 |
Why?
| | Arginine | 1 | 2023 | 238 | 0.190 |
Why?
| | Kinetics | 5 | 2015 | 1551 | 0.190 |
Why?
| | Spinal Cord | 2 | 2021 | 347 | 0.190 |
Why?
| | Receptors, Interleukin | 1 | 2001 | 39 | 0.190 |
Why?
| | Cell Movement | 2 | 2017 | 868 | 0.190 |
Why?
| | Receptors, Interleukin-18 | 1 | 2021 | 15 | 0.190 |
Why?
| | Immune Evasion | 1 | 2021 | 47 | 0.190 |
Why?
| | Mice | 12 | 2023 | 14860 | 0.180 |
Why?
| | Protein Renaturation | 1 | 2000 | 4 | 0.180 |
Why?
| | Emergency Responders | 1 | 2021 | 33 | 0.180 |
Why?
| | Interleukin-3 | 1 | 2000 | 23 | 0.180 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2000 | 45 | 0.180 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 14 | 0.180 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 25 | 0.180 |
Why?
| | Isomerism | 2 | 2015 | 43 | 0.180 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 51 | 0.180 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 56 | 0.180 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.170 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 143 | 0.170 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 69 | 0.170 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2000 | 122 | 0.170 |
Why?
| | Gout | 1 | 2020 | 36 | 0.170 |
Why?
| | Arthritis | 1 | 2020 | 109 | 0.170 |
Why?
| | Interleukin-18 | 1 | 2021 | 219 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 164 | 0.170 |
Why?
| | Allosteric Regulation | 2 | 2017 | 81 | 0.170 |
Why?
| | Complement C3d | 2 | 2010 | 60 | 0.160 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 130 | 0.160 |
Why?
| | Spliceosomes | 2 | 2017 | 38 | 0.160 |
Why?
| | Monocarboxylic Acid Transporters | 2 | 2017 | 20 | 0.160 |
Why?
| | Prescription Drugs | 1 | 2021 | 116 | 0.160 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 221 | 0.160 |
Why?
| | Enzyme Inhibitors | 2 | 2014 | 750 | 0.160 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 78 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 532 | 0.160 |
Why?
| | Receptors, Complement 3d | 2 | 2010 | 130 | 0.160 |
Why?
| | Asparagine | 1 | 2018 | 29 | 0.160 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 2710 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 77 | 0.150 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.150 |
Why?
| | Static Electricity | 3 | 2014 | 114 | 0.150 |
Why?
| | Glucose | 2 | 2021 | 896 | 0.150 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 14 | 0.150 |
Why?
| | Interleukin-17 | 1 | 2018 | 104 | 0.150 |
Why?
| | Psoriasis | 1 | 2018 | 74 | 0.150 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2017 | 11 | 0.150 |
Why?
| | Spinal Cord Injuries | 1 | 2020 | 174 | 0.150 |
Why?
| | Endothelial Cells | 2 | 2019 | 681 | 0.150 |
Why?
| | Models, Chemical | 3 | 2016 | 248 | 0.140 |
Why?
| | Evolution, Molecular | 1 | 2021 | 430 | 0.140 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.140 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 14 | 0.140 |
Why?
| | Tyrosine | 1 | 1998 | 214 | 0.140 |
Why?
| | Nitrogen Isotopes | 3 | 2012 | 55 | 0.140 |
Why?
| | Point Mutation | 2 | 2009 | 216 | 0.140 |
Why?
| | Molecular Chaperones | 1 | 2017 | 157 | 0.130 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 133 | 0.130 |
Why?
| | Protein Structure, Quaternary | 3 | 2011 | 115 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 142 | 0.130 |
Why?
| | RNA Splicing | 1 | 2017 | 245 | 0.130 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 129 | 0.130 |
Why?
| | Tumor Burden | 1 | 2017 | 259 | 0.130 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 270 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3531 | 0.130 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 23 | 0.130 |
Why?
| | Cell Adhesion | 1 | 2017 | 431 | 0.120 |
Why?
| | Hemorrhagic Fever, Crimean | 1 | 2015 | 1 | 0.120 |
Why?
| | Mice, Nude | 1 | 2017 | 630 | 0.120 |
Why?
| | Calcium Signaling | 1 | 2017 | 213 | 0.120 |
Why?
| | RNA Interference | 1 | 2017 | 433 | 0.120 |
Why?
| | Ubiquitin | 1 | 2015 | 57 | 0.120 |
Why?
| | Transfection | 1 | 2017 | 866 | 0.120 |
Why?
| | Signal Transduction | 3 | 2022 | 4509 | 0.120 |
Why?
| | Cold Temperature | 1 | 2015 | 126 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2018 | 663 | 0.120 |
Why?
| | alpha-Synuclein | 1 | 2014 | 21 | 0.120 |
Why?
| | Histidine | 1 | 2014 | 57 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 282 | 0.110 |
Why?
| | Proline | 1 | 2014 | 72 | 0.110 |
Why?
| | Aged | 5 | 2022 | 19061 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2013 | 68 | 0.110 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 147 | 0.110 |
Why?
| | HIV-1 | 3 | 2010 | 768 | 0.100 |
Why?
| | Hydrogen | 1 | 2012 | 59 | 0.100 |
Why?
| | Carbon Isotopes | 1 | 2012 | 111 | 0.100 |
Why?
| | Capsid Proteins | 2 | 2010 | 69 | 0.100 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 821 | 0.100 |
Why?
| | Protein Transport | 1 | 2013 | 395 | 0.100 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1143 | 0.100 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1016 | 0.100 |
Why?
| | Gene Expression | 1 | 2017 | 1421 | 0.100 |
Why?
| | Metabolomics | 3 | 2021 | 521 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 386 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1141 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2021 | 1947 | 0.100 |
Why?
| | Aging | 1 | 2021 | 1618 | 0.090 |
Why?
| | Capsid | 2 | 2002 | 75 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4689 | 0.090 |
Why?
| | Receptors, IgE | 1 | 2010 | 40 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2020 | 353 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 807 | 0.090 |
Why?
| | Hydrogen Bonding | 3 | 2009 | 143 | 0.090 |
Why?
| | PII Nitrogen Regulatory Proteins | 1 | 2009 | 1 | 0.090 |
Why?
| | Time Factors | 2 | 2018 | 6112 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 372 | 0.090 |
Why?
| | Glycolysis | 2 | 2021 | 226 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 591 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2186 | 0.080 |
Why?
| | Multigene Family | 1 | 2010 | 190 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2014 | 345 | 0.080 |
Why?
| | Syndecan-1 | 1 | 2009 | 27 | 0.080 |
Why?
| | Primary Cell Culture | 2 | 2021 | 149 | 0.080 |
Why?
| | Protein Denaturation | 2 | 2017 | 68 | 0.080 |
Why?
| | Brain | 1 | 2021 | 2371 | 0.080 |
Why?
| | Models, Biological | 4 | 2021 | 1620 | 0.080 |
Why?
| | Circular Dichroism | 2 | 2017 | 135 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 186 | 0.080 |
Why?
| | Protein Engineering | 1 | 2009 | 98 | 0.080 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 923 | 0.080 |
Why?
| | Protein Isoforms | 1 | 2009 | 338 | 0.070 |
Why?
| | Adenylate Kinase | 2 | 2005 | 26 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2001 | 616 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 493 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1472 | 0.070 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 54 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1040 | 0.070 |
Why?
| | Virion | 1 | 2007 | 73 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 298 | 0.070 |
Why?
| | Calorimetry | 2 | 2017 | 60 | 0.060 |
Why?
| | Pliability | 1 | 2005 | 45 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2319 | 0.060 |
Why?
| | Escherichia coli | 2 | 2017 | 720 | 0.060 |
Why?
| | Male | 9 | 2021 | 55554 | 0.060 |
Why?
| | Female | 7 | 2021 | 59466 | 0.060 |
Why?
| | Phosphorylation | 2 | 2020 | 1569 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2021 | 2565 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 511 | 0.060 |
Why?
| | Enzymes | 1 | 2005 | 62 | 0.060 |
Why?
| | Movement | 1 | 2005 | 244 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 79 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 51 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 74 | 0.050 |
Why?
| | Cytokines | 2 | 2020 | 1840 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 3003 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 351 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 101 | 0.050 |
Why?
| | Receptors, Interleukin-13 | 1 | 2001 | 2 | 0.050 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 3 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1002 | 0.050 |
Why?
| | Receptors, Interleukin-4 | 1 | 2001 | 15 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 47 | 0.050 |
Why?
| | Macrophage Activation Syndrome | 1 | 2021 | 12 | 0.050 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 26 | 0.050 |
Why?
| | Ranitidine | 1 | 2021 | 13 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 41 | 0.050 |
Why?
| | Candida albicans | 1 | 2021 | 50 | 0.050 |
Why?
| | Solutions | 1 | 2001 | 146 | 0.050 |
Why?
| | Maltose-Binding Proteins | 1 | 2000 | 10 | 0.050 |
Why?
| | Microspheres | 1 | 2021 | 123 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 138 | 0.050 |
Why?
| | Immunoassay | 1 | 2021 | 95 | 0.050 |
Why?
| | Hemolysis | 1 | 2021 | 146 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2001 | 323 | 0.040 |
Why?
| | Avian Sarcoma Viruses | 1 | 2000 | 4 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 71 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2001 | 206 | 0.040 |
Why?
| | Disulfides | 1 | 2000 | 90 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 318 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 26719 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 77 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 197 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 573 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 413 | 0.040 |
Why?
| | Motion | 1 | 2020 | 90 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 1999 | 33 | 0.040 |
Why?
| | Protein Sorting Signals | 1 | 1999 | 16 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 123 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 545 | 0.040 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2019 | 37 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 189 | 0.040 |
Why?
| | Uric Acid | 1 | 2020 | 148 | 0.040 |
Why?
| | Adult | 4 | 2021 | 30528 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 315 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 1727 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 785 | 0.040 |
Why?
| | Titrimetry | 2 | 2009 | 9 | 0.040 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 1998 | 7 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 208 | 0.040 |
Why?
| | Periplasm | 1 | 2017 | 10 | 0.040 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 15 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2021 | 520 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1998 | 193 | 0.040 |
Why?
| | Ultracentrifugation | 1 | 2017 | 46 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2020 | 370 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2021 | 719 | 0.040 |
Why?
| | Protein Unfolding | 1 | 2017 | 31 | 0.040 |
Why?
| | Machine Learning | 1 | 2021 | 316 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1998 | 200 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2000 | 633 | 0.040 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 81 | 0.040 |
Why?
| | Keratinocytes | 1 | 2018 | 216 | 0.040 |
Why?
| | NF-kappa B | 1 | 2021 | 638 | 0.040 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| | Cell Respiration | 1 | 2017 | 74 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 610 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 574 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 695 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 733 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2017 | 522 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 76 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 155 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 211 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1139 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 172 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 194 | 0.030 |
Why?
| | Running | 1 | 2017 | 207 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1176 | 0.030 |
Why?
| | Buffers | 1 | 2014 | 53 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 73 | 0.030 |
Why?
| | Skin | 1 | 2018 | 655 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 544 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 43 | 0.030 |
Why?
| | Electrochemistry | 1 | 2014 | 79 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 101 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 145 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 262 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 3881 | 0.030 |
Why?
| | Proteomics | 1 | 2018 | 836 | 0.030 |
Why?
| | Rats | 1 | 2020 | 4958 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 17831 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2084 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4099 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2537 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2010 | 95 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2009 | 138 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2010 | 155 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6344 | 0.020 |
Why?
| | Spectrum Analysis, Raman | 1 | 2008 | 41 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 296 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2007 | 38 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 797 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2007 | 135 | 0.020 |
Why?
| | Isoenzymes | 1 | 2007 | 283 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10455 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2010 | 766 | 0.020 |
Why?
| | Computer Simulation | 1 | 2009 | 872 | 0.020 |
Why?
| | Water | 1 | 2008 | 396 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2002 | 91 | 0.010 |
Why?
| | Virulence | 1 | 2002 | 227 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2002 | 289 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2000 | 410 | 0.010 |
Why?
| | Models, Structural | 1 | 1999 | 37 | 0.010 |
Why?
| | Drug Design | 1 | 1999 | 148 | 0.010 |
Why?
|
|
Eisenmesser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|